|
⚲
|
| Keyboard |
| van Hauwermeiren Timothy
✚
|
|
|---|---|
| CIK # | 0001816206 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001816206] | |
| 4 | [0001816206] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| van Hauwermeiren Timothy | |
| Lexeo Therapeutics Inc | |
| Denali Therapeutics Inc | |
| iTeos Therapeutics Inc | |
| RayzeBio Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Denali Therapeutics Inc DNLI
Stock Option (right to buy) · derivative
|
2025-11-04 | Grant | 31,897 | $0.00 | |
|
Denali Therapeutics Inc DNLI
Common Stock
|
2025-11-04 | Grant | 10,632 | $0.00 | |
|
Lexeo Therapeutics Inc LXEO
Stock Option (right to buy) · derivative
|
2025-06-26 | Grant | 22,916 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2025-05-13 | Option exercise | 22,346 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2025-05-13 | Option exercise | 22,346 | $4.30 | 96,088 |
|
Lexeo Therapeutics Inc LXEO
Stock Option (right to buy) · derivative
|
2024-07-05 | Grant | 36,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 24,200 | $0.00 | |
|
RayzeBio Inc RYZB
Stock Option (Right to Buy) · derivative
|
2024-02-26 | Disposed to issuer | 48,628 | ||
|
RayzeBio Inc RYZB
Stock Option (right to buy) · derivative
|
2023-11-01 | Grant | 48,628 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2023-06-13 | Grant | 22,383 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2022-06-09 | Grant | 17,538 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2021-06-17 | Grant | 16,608 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2020-07-23 | Grant | 16,608 | $0.00 |